Pengaruh ROA, EPS, Dan DER Terhadap Return Saham (Pada Perusahaan Sektor Healthcare Yang Terdaftar Di Bursa Efek Indonesia Periode 2017-2021)
Abstract
This study aims to determine the effect of Return On Assets (ROA), Earnings per Share (EPS), and Debt to Equity Ratio (DER) on Stock Returns in Healthcare Sector companies listed on the Indonesia Stock Exchange in the 2017-2021 period, either partially or partially. simultaneous. This company focuses on Healthcare sector companies listed on the Indonesia Stock Exchange (IDX) for the period 2017-2021. Based on the sampling criteria, the research sample obtained is 12 companies with a total of 25 observations using purposive sampling method. This research is quantitative descriptive. Based on its function, this study aims to analyze data on companies in the Healthcare sector. The data used is descriptive statistical analysis test, followed by classical assumption test including normality test, multicollinearity test, autocorrelation test, heteroscedasticity test, and the statistical method used to analyze the data using multiple linear regression analysis. The data in this study are secondary data with a time per year for 5 years starting from 2017-2021 obtained from the Indonesia Stock Exchange (IDX). The results showed that the best company, namely the company PT. Indofarma Tbk (INAF) with an average score of 153.69. While the results of multiple linear regression analysis to determine the effect of ROA, EPS, and DER on Stock Returns show that partially ROA has a positive effect on Stock Return, with a value of tcount 3.650 > ttable 2.003. EPS has a positive effect on stock returns, with a tcount of 2,623 > ttable of 2,003. DER has a positive effect on Stock Return with a tcount value of 5.820 > ttable 2003. Simultaneously ROA, EPS, and DER together have a positive effect on Stock Return with Fcount 32,266 > Ftable 2.76..
Downloads
Copyright (c) 2023 Yun Fitriano, Delpania Delpania, Nenden Restu Hidayah
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
An author who publishes in the EKOMBIS REVIEW: Jurnal Ilmiah Ekonomi dan Bisnis agrees to the following terms:
Author retains the copyright and grants the journal the right of first publication of the work simultaneously licensed under the Creative Commons Attribution-ShareAlike 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal
Submission of a manuscript implies that the submitted work has not been published before (except as part of a thesis or report, or abstract); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors. If and when the manuscript is accepted for publication, the author(s) still hold the copyright and retain publishing rights without restrictions. For the new invention, authors are suggested to manage its patent before published. The license type is CC-BY-SA 4.0.
EKOMBIS REVIEW: Jurnal Ilmiah Ekonomi dan Bisnis is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.